CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-11 | SCHIFF ANDREW N Director | Sale | −41,160 | $17.06 | $702K | 435,826 |
| 2022-11-10 | SCHIFF ANDREW N Director | Sale | −11,395 | $17.02 | $194K | 476,986 |
| 2022-11-08 | Powell Andrew Kenneth William Director | Gift | −4,000 | 9,856 | ||
| 2022-10-26 | SCHIFF ANDREW N Director | Sale | −14,540 | $17.01 | $247K | 488,381 |
| 2022-10-25 | SCHIFF ANDREW N Director | Sale | −12,018 | $17.02 | $205K | 502,921 |
| 2022-10-24 | SCHIFF ANDREW N Director | Sale | −14,616 | $17.01 | $249K | 514,939 |
| 2022-10-18 | SCHIFF ANDREW N Director | Sale | −32,093 | $16.89 | $542K | 529,555 |
| 2022-10-17 | SCHIFF ANDREW N Director | Sale | −19,944 | $16.05 | $320K | 561,648 |
| 2022-10-17 | Monahan Joseph Chief Scientific Officer | Sale | −5,000 | $15.98 | $80K | 101,386 |
| 2022-10-07 | SCHIFF ANDREW N Director | Sale | −7,324 | $16.16 | $118K | 581,592 |
| 2022-10-06 | SCHIFF ANDREW N Director | Sale | −37,839 | $16.54 | $626K | 588,916 |
| 2022-10-04 | SCHIFF ANDREW N Director | Sale | −7,700 | $16.01 | $123K | 626,755 |
| 2022-08-01 | Manion Douglas J. Pres and COO | Grant or award · Employee Stock Option (Right to Buy) | +217,800 | 217,800 | ||
| 2022-08-01 | Manion Douglas J. Pres and COO | Grant or award · Restricted Stock Units | +62,300 | 62,300 | ||
| 2022-07-01 | Cawkwell Gail Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2022-07-01 | Cawkwell Gail Chief Medical Officer | Grant or award · Restricted Stock Units | +60,000 | 60,000 | ||
| 2022-06-17 | SCHIFF ANDREW N Director | Sale | −19,565 | $15.14 | $296K | 0 |
| 2022-06-03 | SCHIFF ANDREW N Director | Option exercise | +3,356 | 19,565 | ||
| 2022-06-03 | SCHIFF ANDREW N Director | Option exercise · Restricted Stock Units | −3,356 | 0 | ||
| 2022-06-03 | Reasons Bryan M. Director | Option exercise | +3,356 | 19,565 |
Page 23 of 34 · 680 trades